CSBR
Champions Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.22
−1.14%Jul 27, 2026, 20:00 UTC
Champions Oncology reported record annual revenue of $59.4 million for fiscal year 2026, with fourth quarter revenue of $13.8 million and positive adjusted EBITDA for the fourth consecutive quarter.